1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT)

NICE guideline [NG200] Published: 29 July 2021

  • Guidance
  • Tools and resources
  • History
  • Overview
  • Recommendations
Download guidance (PDF)

Guidance

Recommendations

Recommendations

  • How to use this guideline

  • Introduction

  • Identifying suspected VITT

  • Investigations and diagnosis

    • Initial investigations

    • Further care when VITT is unlikely

    • Further investigations for probable VITT

  • Management

    • Person-centred care

    • Managing thrombosis

      • Anticoagulants

      • Additional considerations for treating thrombosis

    • Managing the VITT immune response

      • Initial treatment

      • Further treatments

      • Intensive treatment for people with signs of poor prognosis

    • Ongoing management

      • Patient-centred care

      • Monitoring response and treating relapse

  • Reporting cases

  • Further vaccination

  • Equality considerations

    • Equalities impact assessment during scoping

    • Equalities impact assessment during guideline development

  • Methods and processes

ISBN: 978-1-4731-4236-7